Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adsorption-free DTacP Vaccine Phase III in Infants
NCT07112144Phase 3Recruiting
- Sponsor
- Changchun BCHT Biotechnology Co.
- Start
- Jun 2025
- Primary completion
- Jun 2032
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of diphtheria + tetanus + acellular pertussis vaccine in pertussis, diphtheria, Tetanus, sponsored by Changchun BCHT Biotechnology Co.. Started Jun 2025; status: recruiting.
02
Drugs
diphtheria + tetanus + acellular pertussis vaccine
03
Conditions
pertussisdiphtheriaTetanus
Beyond the preview
Go deeper on NCT07112144.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07112144.